2019

27 mars

29 mars

Cours 2e & 3e cycle universitaire

5th Workshop on Dendritic Cell Biology

From Biology to the Clinic

This fifth workshop will focus on anti-tumor Immunotherapy. It consists in treating cancer by stimulating the immune system to efficiently attack tumor cells. Speakers will include internationally renowned scientists that will provide a general overview of the basic, translational, and clinical research in the field.

Registrations closed

Cours en Anglais

Date limite d'inscription

12 mars 2019

Présentation
Documents et liens
Informations pratiques
Intervenants

Présentation

Objectifs

The aim of this course is a better understanding of how the immune system actors including dendritic cells, detect and fight tumor cells and how their activities can be boosted.

Programme

Format pdf - Taille octets

Discussion et travail pratique

Poster presentation is optional.

Thèmes de recherche

Travail pratique

Présentation d’un poster

Téléchargez le programme détaillé

Informations pratiques

Infos pratiques

Registration is free and open to all the members of the DCBIOL LabEx community (Institut Curie, Paris and CIML, Marseille), to the IMOCA industrial chair members and to international scientists and MDs working in the field (subscription of young scientists and MDs will be privileged). Students outside of the DBIOL LabEx will have to pay for flight tickets, hotel and dinners.

If you are a PALOP national working in a PALOP country (either as a researcher or medical doctor) and under 45 years old you can apply for a grant financed by Fundação Calouste Gulbenkian.

For more information, please write to joao.vilhena [at] curie.fr

The Sociedade Brasileira de Imunologia offers one travel grant: for more info and to apply, please click HERE

Il n'y a pas de frais d’inscription pour ce cours

Lieu

Champalimaud Foundation

Av. Brasília, 1400-038 Lisboa, Portugal

Effectif maximum

80 personnes

Effectifs

Conditions de selection

A student selection will be made based on CV and motivation.

Intervenants

Bruno Santos (Instituto de Medicina Molecular - PT)

Eliane Piaggio (Institut Curie, Paris - FR)

Emanuela Romano (Institut Curie, Center for Cancer Immunotherapy, Paris - FR)

Gabriel Nuñez (University of Michigan, Sabbatical in Lisbon - PT)

Henrique Veiga-Fernandes (Champalimaud Foundation - PT)

Hidde Ploegh (Boston Children's Hospital - USA)

Julie Helft (Institut Curie, Paris - FR)

Kim Margolin (City of Hope National Medical Center - USA)

Laurie Menger (Institut Curie, Paris - FR)

Luís Moita (Instituto Gulbekian Ciência - PT)

Markus Maeurer (Champalimaud Foundation - PT)

Miguel Soares (Instituto Gulbekian Ciência - PT)

Luis Graça (Instituto de Medicina Molecular - PT)

Onur Boyman (University of Zurich - CH)

Philippe Benaroch (Institut Curie, Paris - FR)

Philippe Pierre (CIML, Marseille - FR)

Pierre Guermonprez (King's College, London - UK and Hôpital Bichat, Paris - FR)

Santiago Zelenay (Manchester University - UK)

Sebastian Amigorena (Institut Curie, Center for Cancer Immunotherapy, Paris - FR)

Vincenzo Bronte (University of Verona - IT)

Keynote speakers

Vincenzo Bronte (University of Verona - IT)

Miriam Merad (Mount Sinai Hospital, NYC - USA)

Hidde Ploegh (Boston Children's Hospital - USA)

Santiago Zelenay (Manchester University - UK)

Kim Margolin (Fred Hutchinson Cancer Research Center, City of Hope - USA)

Markus Maeurer (Champalimaud Foundation - PT)

Onur Boyman (University of Zurich - CH)

Gabriel Nuñez (University of Michigan, Sabbatical in Lisbon - PT)

Miguel Soares (Instituto Gulbekian Ciência - PT)

Organisateurs

DCBIOL & The Training Unit - Institut Curie

Champalimaud Foundation

Comité scientifique

Sebastian Amigorena (Institut Curie); Markus Maeurer (Champalimaud Foundation); Luís Moita (Instituto Gulbenkian Ciência); Emanuela Romano (Institut Curie) ; Bruno Santos (Instituto de Medicina Molecular); Henrique Veiga-Fernandes (Champalimaud Foundation)